| LP416451-5 | Cortisol^5M pre 1 ug/kg CRH IV | COMPONENT | 1 |
| LP416452-3 | Creatinine^1H post dose vasopressin | COMPONENT | 1 |
| LP416453-1 | Creatinine^2H post dose vasopressin | COMPONENT | 1 |
| LP416454-9 | Hydrogen/Expired gas^1.5H post dose carbohydrate | COMPONENT | 1 |
| LP416455-6 | Hydrogen/Expired gas^15M post dose carbohydrate | COMPONENT | 1 |
| LP416456-4 | Hydrogen/Expired gas^1H post dose carbohydrate | COMPONENT | 1 |
| LP416457-2 | Hydrogen/Expired gas^2H post dose carbohydrate | COMPONENT | 1 |
| LP416458-0 | Hydrogen/Expired gas^30M post dose carbohydrate | COMPONENT | 1 |
| LP416459-8 | Hydrogen/Expired gas^45M post dose carbohydrate | COMPONENT | 1 |
| LP416460-6 | Hydrogen/Expired gas^post dose carbohydrate | COMPONENT | 1 |
| LP416461-4 | Hydrogen/Expired gas^pre dose carbohydrate | COMPONENT | 1 |
| LP416462-2 | Methane/Expired gas^1.5H post dose carbohydrate | COMPONENT | 1 |
| LP416463-0 | Methane/Expired gas^15M post dose carbohydrate | COMPONENT | 1 |
| LP416464-8 | Methane/Expired gas^1H post dose carbohydrate | COMPONENT | 1 |
| LP416465-5 | Methane/Expired gas^2H post dose carbohydrate | COMPONENT | 1 |
| LP416466-3 | Methane/Expired gas^30M post dose carbohydrate | COMPONENT | 1 |
| LP416467-1 | Methane/Expired gas^45M post dose carbohydrate | COMPONENT | 1 |
| LP416468-9 | Methane/Expired gas^post dose carbohydrate | COMPONENT | 1 |
| LP416469-7 | Methane/Expired gas^pre dose carbohydrate | COMPONENT | 1 |
| LP416470-5 | Osmolality^1H post dose vasopressin | COMPONENT | 2 |
| LP416471-3 | Osmolality^2H post dose vasopressin | COMPONENT | 2 |
| LP416472-1 | Oxygen consumption/Body weight^peak during exercise | COMPONENT | 1 |
| LP416473-9 | Oxygen consumption/Heart rate^peak during exercise | COMPONENT | 1 |
| LP416478-8 | Potassium^1H post dose vasopressin | COMPONENT | 1 |
| LP416479-6 | Potassium^2H post dose vasopressin | COMPONENT | 1 |
| LP416480-4 | Sodium^1H post dose vasopressin | COMPONENT | 1 |
| LP416481-2 | Sodium^2H post dose vasopressin | COMPONENT | 1 |
| LP416482-0 | Urea nitrogen^1H post dose vasopressin | COMPONENT | 1 |
| LP416483-8 | Urea nitrogen^1H specimen | COMPONENT | 1 |
| LP416484-6 | Urea nitrogen^2H post dose vasopressin | COMPONENT | 1 |
| LP416488-7 | Tumor type treated with radiotherapy | COMPONENT | 1 |
| LP416492-9 | Guidance for intrathecal injection | COMPONENT | 1 |
| LP416494-5 | Gene product metabolic activity interpretation | COMPONENT | 1 |
| LP416906-8 | Busulfan | CHALLENGE | |
| LP416909-2 | MYCN gene | COMPONENT | |
| LP416912-6 | EWSR1 gene | COMPONENT | |
| LP416913-4 | FOXO1 gene | COMPONENT | |
| LP416917-5 | CYP4F2 gene | COMPONENT | |
| LP416920-9 | MDM2 gene | COMPONENT | |
| LP416921-7 | SS18 gene | COMPONENT | |
| LP416923-3 | Mean systole gradient | COMPONENT | 1 |
| LP416925-8 | HEDIS 2020 Value Set - Systolic Blood Pressure | COMPONENT | 1 |
| LP416926-6 | HEDIS 2020 Value Set - Diastolic Blood Pressure | COMPONENT | 1 |
| LP417101-5 | Relationship to patient's mother | COMPONENT | 1 |
| LP417102-3 | Carbon dioxide production | DIVISORS | |
| LP417211-2 | Protein catabolic rate^^adjusted for body weight | COMPONENT | 1 |
| LP417215-3 | B-bump | COMPONENT | 1 |
| LP417219-5 | F2 gene.c.20210G>A and c.1691G>A panel | COMPONENT | 1 |
| LP417220-3 | Origin of germline genetic variant | COMPONENT | 1 |
| LP417224-5 | 2-Decenedioate | COMPONENT | |